Table of Contents
Topic Summary
A Booming Market Worth Billions
The UAE pharma market was valued at USD 4.15 billion in 2024 and is projected to reach USD 8.02 billion by 2033. Dubai alone accounts for close to 40 per cent of that market, making it a prime location for wholesale suppliers.
What This Business Activity Actually Covers
A Wholesale of Pharmaceutical and Medical Goods license lets you buy medicines and medical goods in bulk from makers or importers and sell them to pharmacies, clinics, and hospitals. It is a B2B supply role, not retail or manufacturing.
Know the Clear Exclusions Before You Start
This license does not permit selling medicines directly to patients, manufacturing pharmaceutical products, or providing medical care. Each of those activities requires its own separate license and regulatory framework.
Regulator Approval Is a Must-Have Step
Before Meydan Free Zone can issue your business license, you must obtain pre-approval from the Emirates Drug Establishment (EDE). This third-party approval is a non-negotiable compliance requirement for this activity.
Five Key Drivers Fueling Sector Growth
Demand is rising due to a growing population, increased government health spending, higher rates of chronic illness, a thriving health tourism industry, and expanding local pharmaceutical manufacturing. These factors combine to create strong, sustained demand for bulk suppliers.
Who Should Consider This License?
This activity suits firms that import and distribute medicines in bulk, as well as companies supplying medical goods to healthcare providers. It consolidates bulk pharmaceutical and medical supply under a single license.
How to Start a Wholesale of Pharmaceutical and Medical Goods Business in Dubai with Meydan Free Zone?
This activity is the business of supplying medicines and medical goods in bulk. You buy from makers or import firms. You then sell to pharmacies, clinics and hospitals. In the UAE, this sits inside a fast-growing health sector.
The market is large and rising. The UAE pharma market was worth about USD 4.15 billion in 2024. It is set to reach USD 8.02 billion by 2033. 1 Dubai alone makes up close to 40 per cent of that market. 1 The wider UAE health market may reach USD 19.5 billion by 2025. 2
For suppliers, this means strong and steady demand. A Meydan Free Zone business license lets you trade these goods in bulk. It does need approval from the drug regulator first, as shown below.
[blockCTATradeLicense]
Why the Market Keeps Growing
- Growing population: More people means more need for medicines.
- Health spending: The UAE puts a lot into hospitals and care.
- Long-term illness: Rising chronic needs lift medicine use.
- Health tourism: Many visitors come to the UAE for care.
- Local making: More medicines are now made in the UAE.
Inside the UAE Pharma Market
The UAE has one of the region's fastest-growing pharma markets. Here are the key numbers.
Sources: IMARC Group
Who Is This Activity For?
4649.08 – Wholesale of Pharmaceutical and Medical Goods
This activity sits within the broader Wholesale of Other Household Goods class. That class covers the bulk sale of many goods. The bulk sale of medicines and medical goods is one of them. It means you supply these goods to businesses, not to the public.
The license covers bulk supply. It does not cover selling to patients, which a pharmacy does. It also does not cover making the medicines, or giving care. Those are separate activities, as shown in the exclusions below.
[blockFaqsCategory]
It helps to be clear on what this license does not cover. It does not let you sell medicines to patients direct. That is retail pharmacy, a separate activity. It does not cover making medicines, which is a factory activity. It also does not cover care or giving out medicines to patients. Each of these is a separate activity with its own rules.
In short: if you are supplying medicines and medical goods in bulk to businesses, you are in. If you are selling to patients, making the goods, or giving care, those are separate activities.
[blockCTABizActivityList]
Compliance
THIRD-PARTY APPROVAL
This activity requires pre-approval from the Emirates Drug Establishment (EDE) before a business license can be issued by Meydan Free Zone.
ANTI-MONEY LAUNDERING COMPLIANCE
This business activity is not subject to AML compliance requirements.
References
2 IMARC Group. UAE healthcare market expected to approach USD 19.5 billion by 2025.
